Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bolaget.

Datum Källa Rubrik Typ Alternativ
2023-01-27 ChemoTech Scandinavian ChemoTech publishes clinical strategy update from Medical Director Dr. Suhail Mufti Pressreleaser Ladda ner | Visa Stäng
2023-01-27 ChemoTech Scandinavian ChemoTech publicerar klinisk strategiuppdatering från Medical Director Dr Suhail Mufti Pressreleaser Ladda ner | Visa Stäng
2023-01-24 ChemoTech ChemoTech: TSE-behandlingar vid Royal Veterinary College visar mycket lovande resultat Pressreleaser Ladda ner | Visa Stäng
2023-01-24 ChemoTech ChemoTech: TSE treatments at the Royal Veterinary College shows very promising results Pressreleaser Ladda ner | Visa Stäng
2023-01-20 ChemoTech Scandinavian ChemoTech's Medical Director presents clinical strategy Pressreleaser Ladda ner | Visa Stäng
2023-01-20 ChemoTech Scandinavian ChemoTechs Medical Director presenterar klinisk strategi Pressreleaser Ladda ner | Visa Stäng
2023-01-18 ChemoTech Scandinavian ChemoTech presenterar på Redeye Fight Cancer Day Pressreleaser Ladda ner | Visa Stäng
2023-01-18 ChemoTech Scandinavian ChemoTech presents at Redeye Fight Cancer Day Pressreleaser Ladda ner | Visa Stäng
2023-01-17 ChemoTech ChemoTech: Pancreatic cancer patients in Ukraine treated with Tumour Specific Electroporation™ (TSE) are continuing to improve Pressreleaser Ladda ner | Visa Stäng
2023-01-17 ChemoTech ChemoTech: Bukspottkörtelcancerpatienter i Ukraina som behandlats med Tumörspecific Elektroporation™ (TSE) fortsätter att förbättras Pressreleaser Ladda ner | Visa Stäng
2022-12-21 ChemoTech ChemoTech: TSE-behandlingar utfördes på tre hästar utan generell anestesi vid Royal Veterinary College i London Pressreleaser Ladda ner | Visa Stäng
2022-12-21 ChemoTech ChemoTech: TSE treatments were performed on three horses without general anaesthesia at the Royal Veterinary College in London Pressreleaser Ladda ner | Visa Stäng
2022-12-20 ChemoTech Scandinavian ChemoTech publicerar vd-intervju Pressreleaser Visa Stäng
2022-11-29 ChemoTech Scandinavian ChemoTech changes Certified Adviser till Redeye AB Pressreleaser Ladda ner | Visa Stäng
2022-11-29 ChemoTech Scandinavian ChemoTech byter Certified Adviser till Redeye AB Pressreleaser Ladda ner | Visa Stäng
2022-11-28 ChemoTech Scandinavian ChemoTechs Animal Care-division tecknar betydande kliniskt utvärderingsavtal med The Royal Veterinary College Pressreleaser Ladda ner | Visa Stäng
2022-11-28 ChemoTech Scandinavian ChemoTech's Animal Care division signs significant Clinical Evaluation Agreement with The Royal Veterinary College Pressreleaser Ladda ner | Visa Stäng
2022-11-22 ChemoTech Scandinavian ChemoTech AB publicerar delårsrapport för januari-september 2022 Rapporter Ladda ner | Visa Stäng
2022-11-17 ChemoTech ChemoTech: Important update regarding cancer patients treated with IQwave™ Tumour Specific Electroporation™ (TSE) at Ulis Hospital Ukraine Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 17 Nov 2022 | Scandinavian Chemotech

ChemoTech: Important update regarding cancer patients treated with IQwave™ Tumour Specific Electroporation™ (TSE) at Ulis Hospital Ukraine

The previously published press release stated that one of the pancreatic cancer patients had received conventional chemotherapy with limited response. The tumour was deemed unresectable when Chemotech’s TSE treatment with IQwave under open surgical procedure was chosen as an alternative. After the promising results, the team performed the TSE treatment on yet another patient with pancreatic cancer.

Ulis Hospital now reports that these pancreatic cancer patients have shown an almost 50% decrease in tumour mass. Both patients are mobile and capable of self-care, in no pain and therefore in no needofpainrelief.

The third patient with skin cancer in the groin (inguinal squamous cell carcinoma) has had almost a complete response with TSE, avoiding surgery altogether. A low dose of radiotherapy is currently being given as a precaution for any residual tumour. 

Additionally, the oncology team at Ulis Hospital has also treated one case of tonsillar cancer, which is still to be followed up on and is about to treat a case of locally advanced breast cancer.

”Our two pancreatic cancer patients have shown encouraging results so far. The inguinal skin cancer case has done exceptionally well, and surgery could be avoided. We are happy with the overall performance of the TSE technology. ”- says Alexei Kovalev, Professor at Ulis Hospital

”The results have been highly reassuring and the medical team at ChemoTech will continue to observe the data meticulously for safety, efficacy, and additional indications.” – says Dr Suhail Mufti, Medical of Director Scandinavian ChemoTech

”I can see the IQwave™ TSE technology performing exceptionally well in not only skin cancers but also in difficult-to-treat pancreatic tumours, which is a proof of concept for its application in deep-seated solid tumours. The R&D team at ChemoTech are at work to support clinicians in approaching these deep-seated tumours with minimally invasive approaches.” – says Mohan Frick, CEO of Scandinavian ChemoTech

This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-11-2022 20:45 CET.

2022-11-17 ChemoTech ChemoTech: Viktig uppdatering angående cancerpatienter som behandlats med IQwave™ Tumörspecifik Elektroporation™ (TSE) på Ulis Hospital i Ukraina Pressreleaser Ladda ner | Visa Stäng
2022-10-26 ChemoTech Scandinavian ChemoTech AB offentliggör utfall i företrädesemission Pressreleaser Ladda ner | Visa Stäng
2022-10-26 ChemoTech Scandinavian ChemoTech AB announces outcome in rights issue Pressreleaser Ladda ner | Visa Stäng
2022-10-20 ChemoTech Scandinavian ChemoTech AB publishes supplementary prospectus Pressreleaser Ladda ner | Visa Stäng
2022-10-20 ChemoTech Scandinavian ChemoTech AB offentliggör tilläggsprospekt Pressreleaser Ladda ner | Visa Stäng
2022-10-19 ChemoTech Handel med uniträtter i Scandinavian ChemoTechs pågående emission förlängs Pressreleaser Ladda ner | Visa Stäng
2022-10-19 ChemoTech Trading of unit rights in Scandinavian ChemoTech's ongoing issue is extended Pressreleaser Ladda ner | Visa Stäng
2022-10-19 ChemoTech (RETRANS) ChemoTech's Animal Care division signs Letter of Intent with a prominent player in the North American veterinary market Pressreleaser Ladda ner | Visa Stäng
2022-10-19 ChemoTech (OMS) ChemoTechs Animal Care-division tecknar Letter of Intent med en framstående aktör på den nordamerikanska veterinärmarknaden Pressreleaser Ladda ner | Visa Stäng
2022-10-18 ChemoTech ChemoTech's Animal Care division signs Letter of Intent with a prominent player in the North American veterinary market Pressreleaser Ladda ner | Visa Stäng
2022-10-18 ChemoTech ChemoTechs Animal Care-division tecknar Letter of Intent med en framstående aktör på den nordamerikanska veterinärmarknaden Pressreleaser Ladda ner | Visa Stäng
2022-10-18 ChemoTech Scandinavian ChemoTech's Animal Care division signs exclusive distribution agreement for the Australian and New Zealand market Pressreleaser Ladda ner | Visa Stäng
2022-10-18 ChemoTech Scandinavian ChemoTechs Animal Care-division tecknar exklusivt distributionsavtal för den australiensiska och nyzeeländska marknaden Pressreleaser Ladda ner | Visa Stäng
2022-10-17 ChemoTech Scandinavian ChemoTechs Animal Care-division får order från FloridaWild Veterinary Hospital Pressreleaser Ladda ner | Visa Stäng
2022-10-17 ChemoTech Scandinavian ChemoTech's Animal Care division receives purchase order from FloridaWild Veterinary Hospital Pressreleaser Ladda ner | Visa Stäng
2022-10-13 ChemoTech Board members of Scandinavian ChemoTech fully subscribe to the current issue Pressreleaser Ladda ner | Visa Stäng
2022-10-13 ChemoTech Styrelsemedlemmar i Scandinavian ChemoTech tecknar fullt i pågående emission Pressreleaser Ladda ner | Visa Stäng
2022-10-06 ChemoTech Scandinavian ChemoTech utökar sin ledningsgrupp med ytterligare klinisk kompetens Pressreleaser Ladda ner | Visa Stäng
2022-10-06 ChemoTech Scandinavian ChemoTech expands its management team with further clinical competency Pressreleaser Ladda ner | Visa Stäng
2022-10-03 ChemoTech Scandinavian ChemoTech och India-Sweden Healthcare Innovation Centre firar starten av den kliniska studien på AIIMS Jodhpur Pressreleaser Ladda ner | Visa Stäng
2022-10-03 ChemoTech Scandinavian ChemoTech and the India-Sweden Healthcare Innovation Centre celebrate the start of the clinical trial at AIIMS Jodhpur Pressreleaser Ladda ner | Visa Stäng
2022-09-29 ChemoTech Scandinavian ChemoTech announces postponement of the quarterly report Pressreleaser Ladda ner | Visa Stäng
2022-09-29 ChemoTech Scandinavian ChemoTech meddelar senareläggning av kvartalsrapporten Pressreleaser Ladda ner | Visa Stäng
2022-09-29 ChemoTech Scandinavian ChemoTech offentliggör prospekt med anledning av företrädesemission av units Pressreleaser Ladda ner | Visa Stäng
2022-09-29 ChemoTech Scandinavian ChemoTech publishes prospectus due to rights issue of units Pressreleaser Ladda ner | Visa Stäng
2022-09-28 ChemoTech ChemoTech: Rättelse: Svensk indiske affärsmannen Prashant Agarwal deltar i emissionen som toppgarant Pressreleaser Ladda ner | Visa Stäng
2022-09-28 ChemoTech ChemoTech: Correction: Swedish Indian businessman Prashant Agarwal participates in the share issue as top underwriter Pressreleaser Ladda ner | Visa Stäng
2022-09-23 ChemoTech ChemoTech: Swedish Indian businessman Prashant Agarwal participates in the share issue as top underwriter Pressreleaser Ladda ner | Visa Stäng
2022-09-23 ChemoTech ChemoTech: Svensk indiske affärsmannen Prashant Agarwal deltar i emissionen som toppgarant Pressreleaser Ladda ner | Visa Stäng
2022-09-23 ChemoTech ChemoTech: Bukspottskörtelscancerpatient i Ukraina utskriven efter TSE behandling Pressreleaser Ladda ner | Visa Stäng
2022-09-23 ChemoTech ChemoTech: Pancreatic cancer patient in Ukraine discharged after TSE treatment Pressreleaser Ladda ner | Visa Stäng
2022-09-21 ChemoTech ChemoTech: The Board of Directors resolves on a rights issue of units of approximately SEK 20.1 million Pressreleaser Ladda ner | Visa Stäng
2022-09-21 ChemoTech ChemoTech: Styrelsen beslutar om företrädesemission av units om cirka 20,1 MSEK Pressreleaser Ladda ner | Visa Stäng
2022-09-18 ChemoTech Scandinavian ChemoTechs IQwave™ används för att behandla bukspottkörtelcancer på Ulis sjukhus i Ukraina Pressreleaser Ladda ner | Visa Stäng
2022-09-18 ChemoTech Scandinavian ChemoTech's IQwave™ used to treat pancreatic cancer at Ulis hospital in Ukraine Pressreleaser Ladda ner | Visa Stäng
2022-09-18 ChemoTech Scandinavian ChemoTech's IQwave™ used as first-line treatment with great clinical outcome in Ukraine Pressreleaser Ladda ner | Visa Stäng
2022-09-18 ChemoTech Scandinavian ChemoTechs IQwave™ används som förstahandsbehandling med positivt kliniskt resultat i Ukraina Pressreleaser Ladda ner | Visa Stäng
2022-09-15 ChemoTech ChemoTech: En publicerad fallserie studie indikerar att TSE kan utföras utan generell anestesi Pressreleaser Ladda ner | Visa Stäng
2022-09-15 ChemoTech ChemoTech: A published case series study indicates that TSE can be performed without general anaesthesia Pressreleaser Ladda ner | Visa Stäng
2022-09-05 ChemoTech ChemoTech: TSE-behandling av två hundar på veterinärsjukhuset FloridaWild visar på lovande resultat Pressreleaser Ladda ner | Visa Stäng
2022-09-05 ChemoTech ChemoTech: TSE treatment of two dogs at FloridaWild veterinary hospital shows promising results Pressreleaser Ladda ner | Visa Stäng
2022-09-01 ChemoTech Scandinavian ChemoTech welcomes new energy to its management Pressreleaser Ladda ner | Visa Stäng
2022-09-01 ChemoTech Scandinavian ChemoTech välkomnar ny kraft till ledningen Pressreleaser Ladda ner | Visa Stäng
2022-08-31 ChemoTech Scandinavian ChemoTech's subsidiary Vetiqure AB receives a first order from Hasvet Medikal AS Pressreleaser Ladda ner | Visa Stäng
2022-08-31 ChemoTech Scandinavian ChemoTechs dotterbolag Vetiqure AB erhåller en första order från Hasvet Medikal AS Pressreleaser Ladda ner | Visa Stäng
2022-08-30 ChemoTech Scandinavian ChemoTechs dotterbolag Vetiqure AB skriver exklusivt distributörsavtal för Turkiet med Hasvet Medikal AS Pressreleaser Ladda ner | Visa Stäng
2022-08-30 ChemoTech Scandinavian ChemoTech's subsidiary Vetiqure AB signs an exclusive distributor agreement for Turkey with Hasvet Medikal AS Pressreleaser Ladda ner | Visa Stäng
2022-08-26 ChemoTech Scandinavian ChemoTech's subsidiary Vetiqure AB signs agreement with a German AniCura clinic for participation in a study Pressreleaser Ladda ner | Visa Stäng
2022-08-26 ChemoTech Scandinavian ChemoTechs dotterbolag Vetiqure AB skriver avtal med tysk AniCura-klinik för deltagande i studie Pressreleaser Ladda ner | Visa Stäng
2022-08-16 ChemoTech Scandinavian ChemoTech AB (publ) Interim report Q2 January - June 2022 - Executive Summary Pressreleaser Ladda ner | Visa Stäng
2022-08-16 ChemoTech Scandinavian ChemoTech AB publicerar delårsrapport för januari-juni 2022 Rapporter Ladda ner | Visa Stäng
2022-08-16 ChemoTech Scandinavian ChemoTech strengthens finances by raising a loan of 2.5 MSEK from board and CEO Pressreleaser Ladda ner | Visa Stäng
2022-08-16 ChemoTech Scandinavian ChemoTech stärker finanserna genom att ta upp lån på 2,5 MSEK från styrelse och VD Pressreleaser Ladda ner | Visa Stäng
2022-08-10 ChemoTech ChemoTech: Scandinavian ChemTech får positivt utfall i FloridaWilds utvärdering av vetIQure[TM] Pressreleaser Ladda ner | Visa Stäng
2022-08-10 ChemoTech Scandinavian ChemoTech reaching a positive outcome in FloridaWild's evaluation of vetIQure[™] Pressreleaser Ladda ner | Visa Stäng
2022-07-26 Kalqyl Kalqyl: Initial take: ChemoTech Analyser Ladda ner | Visa Stäng
2022-07-26 ChemoTech Kalqyl publish initial take analysis on Scandinavian ChemoTech Pressreleaser Ladda ner | Visa Stäng
2022-07-26 ChemoTech Kalqyl publicerar uppdragsanalys på Scandinavian ChemoTech Pressreleaser Ladda ner | Visa Stäng
2022-07-20 ChemoTech Scandinavian ChemoTech announces that TSE™ therapy has been initiated at Ulis Medical Centre in Ukraine Pressreleaser Ladda ner | Visa Stäng
2022-07-20 ChemoTech Scandinavian ChemoTech meddelar att TSE™-behandling har inletts vid Ulis Medical Center i Ukraina Pressreleaser Ladda ner | Visa Stäng
2022-07-13 ChemoTech Scandinavian ChemoTech håller den första utbildningen på Ulis Medical Centre i Ukraina Pressreleaser Ladda ner | Visa Stäng
2022-07-13 ChemoTech Scandinavian ChemoTech holds the first training session at Ulis Medical Centre in Ukraine Pressreleaser Ladda ner | Visa Stäng
2022-07-13 ChemoTech Scandinavian ChemoTech announces the receival of ethics committee approval for a clinical trial with the TSE™ technology at `All India Institute of Medical Sciences' (AIIMS) in India Pressreleaser Ladda ner | Visa Stäng
2022-07-13 ChemoTech Scandinavian ChemoTech tillkännager mottagandet av etiskt godkännande för en studie med TSE™-teknologin vid 'All India Institute of Medical Sciences' (AIIMS) i Indien Pressreleaser Ladda ner | Visa Stäng
2022-06-23 ChemoTech Scandinavian ChemoTech ger en lägesrapport och önskar alla en trevlig midsommar och semester Pressreleaser Ladda ner | Visa Stäng
2022-06-23 ChemoTech Scandinavian ChemoTech provides a status report and wishes everyone a pleasant midsummer and holiday Pressreleaser Ladda ner | Visa Stäng
2022-06-21 ChemoTech Scandinavian ChemoTech anlitar IR-konsult Pressreleaser Ladda ner | Visa Stäng
2022-06-21 ChemoTech Scandinavian ChemoTech hires investor relations consultant Pressreleaser Ladda ner | Visa Stäng
2022-06-16 ChemoTech Scandinavian ChemoTech tecknar avtal med Kalqyl om uppdragsanalys Pressreleaser Ladda ner | Visa Stäng
2022-06-16 ChemoTech Scandinavian ChemoTech signs agreement with Kalqyl on assignment analysis Pressreleaser Ladda ner | Visa Stäng
2022-06-03 ChemoTech Scandinavian ChemoTech receives a new patent on the Japanese market Pressreleaser Ladda ner | Visa Stäng
2022-06-03 ChemoTech Scandinavian ChemoTech erhåller nytt patent på den japanska marknaden Pressreleaser Ladda ner | Visa Stäng
2022-05-31 ChemoTech Scandinavian ChemoTech's dotterbolag summerar ett mycket lyckat deltagande på ESVONC Pressreleaser Ladda ner | Visa Stäng
2022-05-31 ChemoTech Scandinavian ChemoTech's subsidiary sums up a very successful participation at ESVONC Pressreleaser Ladda ner | Visa Stäng
2022-05-26 ChemoTech Scandinavian ChemoTechs TSE teknologi ger hopp till hästar som lider av Sarcoider Pressreleaser Ladda ner | Visa Stäng
2022-05-26 ChemoTech Scandinavian ChemoTech's TSE technology gives hope to horses suffering from sarcoids Pressreleaser Ladda ner | Visa Stäng
2022-05-24 ChemoTech Kommuniké från årsstämma i Scandinavian ChemoTech AB (publ) den 24 maj 2022 Pressreleaser Ladda ner | Visa Stäng
2022-05-17 ChemoTech Pressmeddelande Lund 17 maj 2022 Scandinavian ChemoTech erhåller slutligt patentgodkännande i EU för den tumörspecifika kontrollenheten i vår TSE™-plattform Pressreleaser Ladda ner | Visa Stäng
2022-05-17 ChemoTech Press release Lund 17 May 2022 Scandinavian ChemoTech receives final patent approval in the EU for the tumour specific control unit in our TSE™ platform Pressreleaser Ladda ner | Visa Stäng
2022-05-16 ChemoTech Scandinavian ChemoTechs dotterbolag Vetiqure deltar vid ESVONCs kongress i Italien Pressreleaser Ladda ner | Visa Stäng
2022-05-16 ChemoTech Scandinavian ChemoTech's subsidiary Vetiqure participates in ESVONC's congress in Italy Pressreleaser Ladda ner | Visa Stäng
2022-05-09 ChemoTech ChemoTech supports a Ukrainian hospital by selling an IQwave™ at a discounted price Pressreleaser Ladda ner | Visa Stäng
2022-05-09 ChemoTech ChemoTech stödjer ett ukrainskt sjukhus genom att sälja en IQwave™ till rabatterat pris Pressreleaser Ladda ner | Visa Stäng
2022-05-03 ChemoTech Scandinavian ChemoTech gästar Småbolagspodden Pressreleaser Ladda ner | Visa Stäng
2022-05-03 ChemoTech Scandinavian ChemoTech publicerar 2021 års årsredovisning Pressreleaser Visa Stäng
2022-05-03 ChemoTech Scandinavian ChemoTech AB publicerar delårsrapport för januari-mars 2022 Rapporter Ladda ner | Visa Stäng
2022-04-21 ChemoTech Kallelse till årsstämma i Scandinavian ChemoTech AB Pressreleaser Ladda ner | Visa Stäng
2022-04-12 ChemoTech Scandinavian ChemoTech AB nominerade till Swecare Export Awards Pressreleaser Ladda ner | Visa Stäng
2022-04-12 ChemoTech Scandinavian ChemoTech AB nominated for the Swecare Export Awards Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

7 Mar 2023 | Bokslutskommuniké 2022